Novo Nordisk nears EU approval of obesity drug WegovyDanish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment for obesity, Wegovy, in the EU Share XNovo Nordisk nears EU approval of obesity drug Wegovyhttps://pharmaphorum.com/news/novo-nordisk-nears-eu-approval-of-obesity-drug-wegovy/
COVID antibodies from Roche, Celltrion backed for approval in EUThe EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, Share XCOVID antibodies from Roche, Celltrion backed for approval in EUhttps://pharmaphorum.com/news/first-covid-antibodies-from-roche-celltrion-backed-in-eu/
NICE changes tack on ‘game changer’ rare cancer therapy PoteligeoNICE has reversed an earlier decision not to recommend NHS use of Kyowa Kirin’s Poteligeo for two rare Share XNICE changes tack on ‘game changer’ rare cancer therapy Poteligeohttps://pharmaphorum.com/news/nice-changes-tack-on-game-changer-rare-cancer-therapy-poteligeo/
One world, one health: The interconnected web of antimicrobial resistanceTackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and Share XOne world, one health: The interconnected web of antimicrobial resistancehttps://pharmaphorum.com/r-d/interconnected-web-of-antimicrobial-resistance/
Sales coaching: preparing for the new reality in pharmaCOVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an Share XSales coaching: preparing for the new reality in pharmahttps://pharmaphorum.com/whitepapers/pharma-sales-coaching-new-reality/
Leveraging multichannel and multimedia in HCP educationCOVID has forced the pharma industry to step up and take a more innovative approach to the channels Share XLeveraging multichannel and multimedia in HCP educationhttps://pharmaphorum.com/sales-marketing/leveraging-multichannel-and-multimedia-in-hcp-education/
Deep Dive: Patients and PartnershipsAs the world is slowly, gradually, hopefully emerges from the shadow of COVID-19 there’s a unique opportunity to Share XDeep Dive: Patients and Partnershipshttps://pharmaphorum.com/patients/deep-dive-patients-and-partnerships-2021/
How are the European pharma and biotech sectors addressing strategic communications?Stakeholder expectations are high and, with all eyes on healthcare at the moment, it is essential for companies Share XHow are the European pharma and biotech sectors addressing strategic communications?https://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/european-pharma-biotech-strategic-communications/
BMS’ Catherine Owen: Hybrid communication is here to stayThe company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of Share XBMS’ Catherine Owen: Hybrid communication is here to stayhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/bristol-myers-squibb-bms-catherine-owen/
The power of R&D collaborations to improve outcomes in rare diseases Share XThe power of R&D collaborations to improve outcomes in rare diseaseshttps://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/
Using AI to make a big impact for emerging and mid-sized biopharma companies Share XUsing AI to make a big impact for emerging and mid-sized biopharma companieshttps://pharmaphorum.com/webinars/using-ai-to-make-a-big-impact-for-emerging-and-mid-sized-biopharma-companies/
The digital transformation of pharma’s physician engagement strategies Share XThe digital transformation of pharma’s physician engagement strategieshttps://pharmaphorum.com/webinars/digital-transformation-pharma-engagement-p360/
Sales coaching: preparing for the new reality in pharmaCOVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an Share XSales coaching: preparing for the new reality in pharmahttps://pharmaphorum.com/whitepapers/pharma-sales-coaching-new-reality/
Utilising content metrics to improve digital engagementPharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content Share XUtilising content metrics to improve digital engagementhttps://pharmaphorum.com/whitepapers/content-metrics-digital-engagement-veeva/
Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
Merck on trends in oncology: the pharmaphorum podcast Share XMerck on trends in oncology: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/merck-on-trends-in-oncology/
Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast Share XSandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/sandozs-pierre-b…e-on-biosimilars/
Patient engagement strategies: the pharmaphorum podcast Share XPatient engagement strategies: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/patient-engagement-strategies
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group Share XFishawack Health welcomes expert-led dermatology initiative FIDE to its grouphttps://pharmaphorum.com/partner-content/fishawack-health-welcomes-expert-led-dermatology-initiative-fide-to-its-group/
Patient and market insights from leading KOLs and life science leaders Share XPatient and market insights from leading KOLs and life science leadershttps://pharmaphorum.com/partner-content/patient-and-market-insights-from-leading-kols-and-life-science-leaders/
Is there a faster way to build clinical trials? Share XIs there a faster way to build clinical trials?https://pharmaphorum.com/partner-content/is-there-a-faster-way-to-build-clinical-trials/
How digital connectivity is driving faster patient access Share XHow digital connectivity is driving faster patient accesshttps://pharmaphorum.com/partner-content/how-digital-connectivity-is-driving-faster-patient-access/
AXON appoints Colette Balaam as its new US Managing Partner Share XAXON appoints Colette Balaam as its new US Managing Partnerhttps://pharmaphorum.com/partner-content/axon-appoints-colette-balaam-as-its-new-us-managing-partner/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
